探讨手法复位联合甲磺酸倍他司汀片治疗良性阵发性位置性眩晕的疗效

Exploration on the Effect of Manual Reduction Combined with Betahistine Mesylate in the Treatment of Benign Paroxysmal Positional Vertigo

目的分析手法复位联合甲磺酸倍他司汀片治疗良性阵发性位置性眩晕的疗效。方法于2018年10月—2019年10月期间在该院确诊治疗的良性阵发性位置性眩晕患者中随机抽取出100例作为该次研究对象,通过双盲选法将其分为参照组和实验组,各50例。参照组仅安排予以手法复位治疗,实验组则在手法复位治疗基础上再联合予以甲磺酸倍他司汀片治疗。比较组间治疗效果、复发情况以及BBS评分和VSI评分。结果参照组总治疗有效率80.00%显著低于实验组96.00%,总复发率24.00%显著高于实验组8.00%,差异有统计学意义(χ^2=6.061、4.762,P<0.05);参照组治疗后的BBS评分(28.74±4.66)分显著低于实验组(51.17±1.98)分,而VSI评分(35.78±4.28)分显著高于实验组(22.95±5.06)分,差异有统计学意义(t=32.325、13.689,P<0.05)。结论在良性阵发性位置性眩晕患者的临床治疗中,选择手法复位联合甲磺酸倍他司汀片治疗方案进行治疗可以为患者康复带来更大获益,不仅可以有效提高患者的治疗效果以及平衡能力,还可以进一步降低患者复发概率,改善前庭症状以及预后。

Objective To analyze the efficacy of manual reduction combined with betahistine mesylate tablets in the treatment of benign paroxysmal positional vertigo.Methods From October 2018 to October 2019,100 patients with benign paroxysmal positional vertigo diagnosed and treated in the hospital were randomly selected as the research objects,and they were divided into the reference group and the experimental group by double-blind selection method,50 cases in each,the reference group was only arranged to receive manual reduction therapy,and the experimental group was combined with manual reduction therapy and then combined with betahistine mesylate tablets.Compared the treatment effect,recurrence,BBS score and VSI score between groups.Results The total treatment effective rate of 80.00%in the reference group was significantly lower than 96.00%in the experimental group,and the total recurrence rate of 24.00%was significantly higher than that in the experimental group 8.00%.The difference was statistically significant(χ^2=6.061,4.762,P<0.05);after treatment,the BBS score(28.74±4.66)points was significantly lower than the experimental group(51.17±1.98)points,while the VSI score(35.78±4.28)points were significantly higher than the experimental group(22.95±5.06)points,the difference was statistically significant(t=32.325,13.689,P<0.05).Conclusion In the clinical treatment of patients with benign paroxysmal positional vertigo,the choice of manual reduction combined with betahistine mesylate tablets for treatment can bring greater benefits to patients’rehabilitation,and not only can effectively improve the treatment effect of patients as well as balance ability,it can also further reduce the probability of patient recurrence,improve vestibular symptoms and prognosis.